Infectious Disease Researcher Steve Meshnick Dies
Infectious Disease Researcher Steve Meshnick Dies
A leading scientist on the mechanisms of action of antimalarial medications, the University of North Carolina professor made contributions to research and mentoring all around the world.
Infectious Disease Researcher Steve Meshnick Dies
Infectious Disease Researcher Steve Meshnick Dies

A leading scientist on the mechanisms of action of antimalarial medications, the University of North Carolina professor made contributions to research and mentoring all around the world.

A leading scientist on the mechanisms of action of antimalarial medications, the University of North Carolina professor made contributions to research and mentoring all around the world.

drug
Luis Alvarez Aims to Heal Wounds with Tissue-Regenerating “Paint”
Luis Alvarez Aims to Heal Wounds with Tissue-Regenerating “Paint”
Shawna Williams | Jul 13, 2020
The bioactive coating tethers restorative proteins to implanted tissues and fosters new growth, animal studies suggest.
Insight into Dexamethasone’s Benefits in Severe COVID-19
Insight into Dexamethasone’s Benefits in Severe COVID-19
Abby Olena | Jun 19, 2020
The steroid’s exceptional performance in early results from the RECOVERY clinical trial in the United Kingdom is a rational outcome of the drug’s anti-inflammatory effects, experts say.
FDA Approves Previously Rejected Muscular Dystrophy Treatment
FDA Approves Previously Rejected Muscular Dystrophy Treatment
Emily Makowski | Dec 13, 2019
The drug Vyondys 53 has met a surrogate endpoint of protein production, but there’s no clear proof it has a clinical benefit.
Serotonin and Dopamine Responsible for the Pros and Cons of MDMA
Serotonin and Dopamine Responsible for the Pros and Cons of MDMA
Ruth Williams | Dec 11, 2019
A study in mice suggests serotonin release underlies the drug’s prosocial effects while dopamine mediates the rewarding properties that drive its potential for abuse.
Tufts to Remove Sackler Name from Medical Campus
Tufts to Remove Sackler Name from Medical Campus
Emily Makowski | Dec 9, 2019
The school will not return donations from the family that made its riches on opioids, but the university will start a $3 million endowment for addiction prevention and treatment.
Drug-Resistant Flu Can Emerge After Patients Take Antiviral
Drug-Resistant Flu Can Emerge After Patients Take Antiviral
Kerry Grens | Nov 26, 2019
Roughly a quarter of 38 viral samples from people treated with Xofluza had mutations in their genomes that made the pathogens less susceptible to the drug.
Two Professors Accused of Making Meth in Campus Lab
Two Professors Accused of Making Meth in Campus Lab
Emily Makowski | Nov 18, 2019
The Henderson State University academics face charges of manufacturing methamphetamine and using drug paraphernalia.
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
Catherine Offord | Oct 14, 2019
The move will allow the Belgium-headquartered biopharmaceutical giant to boost its work on treatments for rare diseases.
Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Bianca Nogrady | Oct 1, 2019
The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development.